TAF I p110_TAF I p95 Activators encompass a specialized class of chemical compounds that specifically enhance the functional activity of the TAF I p110 and TAF I p95 proteins. These proteins are integral components of the multi-subunit complex known as the Template Activating Factor I (TAF I), which plays a pivotal role in nucleosome assembly and chromatin structure regulation. Activators that target these proteins do so by engaging with specific signaling pathways or molecular processes that are central to the operation of TAF I p110 and TAF I p95. The activation of these proteins typically involves the alteration of chromatin remodeling processes, which can lead to an enhanced accessibility of transcriptional machinery to DNA, thus indirectly promoting gene expression regulation. Chemical activators may influence the post-translational modifications of TAF I p110 and TAF I p95, such as phosphorylation, acetylation, or ubiquitination, leading to conformational changes that augment their activity in nucleosome assembly. These modifications are critical as they can significantly affect the interaction dynamics within the TAF I complex and with other chromatin-associated proteins, thereby modulating the chromatin structure for efficient transcriptional activation.
Moreover, TAF I p110_TAF I p95 Activators might also function by stabilizing the protein complex or by enhancing the interaction with other transcriptional coactivators, thereby providing a more robust platform for transcription initiation. These activators could bond to specific domains of TAF I p110 and TAF I p95, leading to an allosteric change that results in the increased efficiency of nucleosome assembly. This mechanism ensures that the activators are not merely passively interacting with the proteins but are actively promoting the necessary structural and functional conditions that are conducive to their role in gene expression. The specificity of these activators is crucial as it ensures that the enhancement of TAF I p110 and TAF I p95 activity is not overshadowed by a generalized activation of other pathways or proteins that could lead to nonspecific effects. By focusing on the unique pathways and processes that directly involve TAF I p110 and TAF I p95, these activators ensure a targeted and effective modulation of chromatin architecture and transcriptional control, emphasizing their significance in the intricate regulation of gene expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions are essential for the structural integrity of many DNA-binding proteins. Zinc acetate can provide zinc ions that enhance the DNA binding affinity of TAF I p110_TAF I p95, thereby increasing its transcriptional activity. | ||||||
Magnesium chloride | 7786-30-3 | sc-255260C sc-255260B sc-255260 sc-255260A | 10 g 25 g 100 g 500 g | $28.00 $35.00 $48.00 $125.00 | 2 | |
Magnesium ions are cofactors for many enzymes, including those involved in phosphorylation. Magnesium chloride can enhance the functional activity of TAF I p110_TAF I p95 by supporting its interaction with other transcription factors. | ||||||
Sodium Salicylate | 54-21-7 | sc-3520 sc-3520A sc-3520B sc-3520C | 1 g 25 g 500 g 1 kg | $10.00 $26.00 $82.00 $139.00 | 8 | |
Sodium salicylate can inhibit p300, a histone acetyltransferase that competes with TAF I p110_TAF I p95 for binding to the transcriptional machinery, thus indirectly enhancing the activity of TAF I p110_TAF I p95. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide inhibits sirtuins, a class of deacetylases, which can deacetylate lysine residues on histones, potentially increasing the accessibility of DNA to TAF I p110_TAF I p95 and enhancing its activity. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to the minor groove of DNA and can displace regulatory proteins that compete with TAF I p110_TAF I p95, potentially enhancing its binding to DNA. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor which can lead to a more open chromatin structure, enhancing the access of TAF I p110_TAF I p95 to DNA and increasing its transcriptional activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine inhibits DNA methyltransferase leading to reduced DNA methylation. This can enhance the binding of TAF I p110_TAF I p95 to DNA by creating a more permissive transcriptional environment. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can modulate transcription factor activity. Its presence can enhance the activity of TAF I p110_TAF I p95 by facilitating chromatin remodeling, thereby increasing accessibility to transcription complexes. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Beta-Estradiol can modulate transcriptional activity by interacting with estrogen receptors that recruit coactivators and remodel chromatin, thereby potentially enhancing the activity of TAF I p110_TAF I p95 at estrogen-responsive promoters. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride indirectly enhances the activity of TAF I p110_TAF I p95 by inhibiting Na+/H+ exchange and subsequently altering intracellular pH, which can affect transcription factor binding to DNA. | ||||||